Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trop2-ADC Strategies in Advanced TNBC
NCT06851299Phase 2Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Mar 2025
- Primary completion
- Apr 2027
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of Trop2 antibody-drug conjugate in triple negative breast cancer (TNBC), sponsored by Sun Yat-sen Memorial Hospital. Started Mar 2025; status: recruiting.
02
Drugs
Trop2 antibody-drug conjugate
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT06851299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06851299.